A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% lower risk of dementia, among other health benefits. Dr. Archina Sadhu, ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood ...

Researchers say GLP-1 medications like Ozempic and Wegovy may not be as effective for those with emotional eating issues who ...

Weight loss drugs like Mounjaro, Ozempic, and Wegovy may cause changes in how food tastes, how cravings feel and in appetite, ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

And it’s not just vanity on the line. Being overweight or obese increases your risk for a laundry list of serious health problems, including Type 2 diabetes, heart disease, stroke, high blood pressure ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers ...

Some people taking Ozempic, Wegovy, or Mounjaro notice that food suddenly tastes sweeter or saltier, and this subtle shift in ...

One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just ...

Novo Nordisk, the drugmaker behind Ozempic, is laying off thousands of workers as it struggles against competition from other ...